Clindamycin B

• Description:

  Clindamycin B is a derivative of Clindamycin (HY-B1455) [1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302-H315-H319-H335

• Target:

  Antibiotic; Bacterial; Parasite

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/clindamycin-b.html

• Smiles:

  O=C([C@@H]1C[C@H](CN1C)CC)N[C@@H]([C@@]2([H])O[C@@H]([C@@H]([C@H]([C@H]2O)O)O)SC)[C@@H](Cl)C

• Molecular Formula:

  C17H31ClN2O5S

• Molecular Weight:

  410.96

• Precautions:

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations:

  [1]Liquid chromatography method for separation of clindamycin from related substances

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [18323-43-8]